TRIUMF is Canada’s national particle‑physics laboratory, located on the campus of the University of British Columbia in Vancouver, British Columbia. Founded in 1968 as the Tri‑University Meson Facility (the name “TRIUMF” deriving from this original acronym), the institution was established through a partnership among three universities: the University of British Columbia, Simon Fraser University, and the University of Victoria.
Facilities and Research Programs
- Cyclotron: TRIUMF operates a 520 MeV, 5000 kW proton cyclotron, which is the world’s largest of its kind by beam current. The cyclotron provides high‑intensity beams for experiments in fundamental particle and nuclear physics, as well as for the production of radioisotopes used in medicine and industry.
- Isotope Production: The laboratory manufactures a wide range of medically important isotopes, including fluorine‑18 for positron emission tomography (PET) and various therapeutic radionuclides.
- ISAC (Isotope‑Separator and Accelerator): A secondary facility that delivers rare isotope beams for nuclear structure and astrophysics studies.
- Laboratory for Advanced Imaging, Biology, and Medicine (LAI‑B‑M): Supports interdisciplinary research utilizing particle beams for biological and medical investigations.
Collaborations and Funding
TRIUMF is a member of the international particle‑physics community, contributing to experiments at facilities such as CERN (e.g., the CMS and ATLAS detectors) and the Canada‑France‑Hawaii Telescope. Funding is provided principally by the Government of Canada through the National Research Council, with additional support from provincial agencies, university partners, and external research grants.
Educational Role
The centre offers graduate‑level training for students from its partner universities and hosts postdoctoral fellows, technical staff, and visiting scientists. It also runs outreach programs aimed at promoting public understanding of science and technology.
Governance
TRIUMF is governed by a board of directors representing its founding universities and the Canadian government. The laboratory’s strategic direction emphasizes both fundamental research in particle and nuclear physics and the development of applications that benefit health care and industry.